A novel 21-kDa cytochrome c-releasing factor is generated upon treatment of human leukemia U937 cells with geranylgeraniol

Biochemical and Biophysical Research Communications

Volumn 346, Issue 2, 2006, Pages 454-460

  Masuda, Yutaka ^a   Maeda, Sayoko ^a   Watanabe, Akiko ^a   Sano, Yoshihiro ^a   Aiuchi, Toshihiro ^a   Nakajo, Shigeo ^a   Itabe, Hiroyuki ^a   Nakaya, Kazuyasu ^a,b  

^a SHOWA UNIVERSITY   (Japan)

^b NIIGATA UNIVERSITY OF PHARMACY AND APPLIED LIFE SCIENCES   (Japan)

Author keywords

Apoptosis; Cytochrome c; Geranylgeraniol; Mitochondria

Indexed keywords

CYTOCHROME C; GERANYLGERANIOL;

APOPTOSIS; ARTICLE; CONTROLLED STUDY; GENE OVEREXPRESSION; HUMAN; HUMAN CELL; LEUKEMIA CELL; MITOCHONDRION; PRIORITY JOURNAL; TUMOR CELL;

AMINO ACID SEQUENCE; APOPTOSIS; CYTOCHROMES C; DITERPENES; HELA CELLS; HUMANS; MITOCHONDRIA; MITOCHONDRIAL PROTEINS; U937 CELLS;

EID: 33745122924     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2006.05.161     Document Type: Article

References (29)

1. Ucker D.S. Cytotoxic T lymphocytes and glucocorticoids activate an endogeneous suicide process in target cells. Nature 327 (1987) 62-64
2. Laurent-Crawford A.G., Krust B., Muller S., Riviere Y., Rey-Cuille M.A., Bechet J.M., Montagnier L., and Hovanessian A.G. The cytopathic effect of HIV is associated with apoptosis. Virology 185 (1991) 829-839
3. Ohizumi H., Masuda Y., Nakajo S., Sakai I., Ohsawa S., and Nakaya K. Geranylgeraniol is a potent inducer of apoptosis in tumor cells. J. Biochem. 117 (1995) 11-13
4. Farnsworth C.C., Gelb M.H., and Glomset J.A. Identification of geranylgeranyl-modified proteins in HeLa cells. Science 247 (1990) 320-322
5. Kitten G.T., and Nigg E.A. The CaaX motif is required for isoprenylation, carboxyl methylation, and nuclear membrane association of lamin B2. J. Cell Biol. 113 (1991) 13-23
6. Hancock J.T., Magee A.I., Childs J.E., and Marshall C.J. All ras proteins are polyisoprenylated but only some are palmitoylated. Cell 57 (1989) 1167-1177
7. Schafer W.R., Kim R., Sterne R., Thorner J., Kim S.H., and Rine J. Genetic and pharmacological suppression of oncogenic mutations in RAS genes of yeast and humans. Science 245 (1989) 379-384
8. Li X., Liu L., Tupper J.C., Bannerman D.D., Winn R.K., Sebti S.M., Hamilton A.D., and Harlan J.M. Inhibition of protein geranylgeranylation and RhoA/RhoA kinase pathway induces apoptosis in human endothelial cells. J. Biol. Chem. 277 (2002) 15309-15316
9. Tsujimoto Y., and Shimizu S. Bcl-2 family: life-or-death switch. FEBS Lett. 466 (2000) 6-10
10. Martinou J.C., and Green D.R. Breaking the mitochondrial barrier. Nat. Rev. Mol. Cell Biol. 2 (2001) 63-67
11. Wang X. The expanding role of mitochondria in apoptosis. Genes Dev. 15 (2001) 2922-2933
12. Adams J.M., and Cory S. The Bcl-2 protein family: arbiters of cell survival. Science 281 (1998) 1322-1326
13. Antonsson B., Montessuit S., Sanchez B., and Martinou J.C. Bax is present as a high molecular weight oligomer/complex in the mitochondrial membrane of apoptotic cells. J. Biol. Chem. 276 (2001) 11615-11623
14. Wei M.C., Zong W.X., Cheng E.H., Lindsten T., Panoutsakopoulou V., Ross A.J., Roth K.A., MacGregor G.R., Thompson C.B., and Korsmeyer S.J. Proapoptotic BAX and BAK: a requisite gateway to mitochondrial dysfunction and death. Science 292 (2001) 727-730
15. Puthalakath H., and Strasser A. Keeping killers on a tight leash: transcriptional and post-translational control of the pro-apoptotic activity of BH3-only proteins. Cell Death Differ. 9 (2002) 505-512
16. Wyllie A.H. Glucocorticoid-induced thymocyte apoptosis is associated with endogenous endonuclease activation. Nature 284 (1980) 555-556
17. Gottlieb R.A., and Adachi S. Nitrogen cavitation for cell disruption to obtain mitochondria from cultured cells. Methods Enzymol. 322 (2000) 213-221
18. Wolf B.B., and Green D.R. Apoptosis: letting slip the dogs of war. Curr. Biol. 12 (2002) R177-R179
19. Oda E., Ohki R., Murasawa H., Nemoto J., Shibue T., Yamashita T., Koikino T., Tanuguchi T., and Tanaka N. Noxa, a BH3-only member of the Bcl-2 family and candidate mediator of p53-induced apoptosis. Science 288 (2000) 1053-1058
20. Nakano K., and Vousden K.H. PUMA, a novel proapoptotic gene, is induced by p53. Mol. Cell 7 (2001) 683-694
21. Wolter K.G., Hsu Y.T., Smith C.L., Nechushtan A., Xi X.G., and Youle R.J. Movement of Bax from the cytosol to mitochondria during apoptosis. J. Cell Biol. 139 (1997) 1281-1292
22. Gross A., Jockel J., Wei M.C., and Korsmeyer S.J. Enforced dimerization of Bax results in its translocation, mitochondrial dysfunction and apoptosis. EMBO J. 17 (1998) 3878-3885
23. Konishi A., Shimizu S., Hirota J., Takao T., Fan Y., Matsuoka Y., Zhang L., Yoneda Y., Fujii Y., Skoultchi A.I., and Tsujimoto Y. Involvement of histone H1.2 in apoptosis induced by DNA double-strand breaks. Cell 114 (2003) 673-688
24. Sebti S.M., and Hamilton A.D. Inhibition of Ras prenylation: a novel approach to cancer chemotherapy. Pharmacol Ther. 74 (1997) 103-114
25. Miquei K., Pradines A., Sun J., Qian Y., Hamilton A.D., Sebti S.A., and Favre G. GGTI-298 induces G0-G1 block and apoptosis whereas FTI-277 causes G2-M enrichment in A549 cells. Cancer Res. 57 (1997) 665-670
26. Reedquist K.A., Pope T.K., and Roess D.A. Lovastatin inhibits proliferation and differentiation and causes apoptosis in lipopolysaccharide-stimulated murine B cells. Biochem. Biophys. Res. Commun. 211 (1995) 665-670
27. van de Donk N.W., Kamphuis M.N., van Kessel B., Lokhorst H.M., and Bloem A.C. Inhibition of protein geranylgeranylation induces apoptosis in myeloma plasma cells by reducing Mcl-1 protein levels. Blood 102 (2003) 3354-3362
28. Miquel K., Pradines A., Terce F., Selmi S., and Favre G. Competitive inhibition of choline phosphotransferase by geranylgeraniol and farnesol inhibits phosphatidylcholine synthesis and induces apoptosis in human lung adenocarcinoma A549 cells. J. Biol. Chem. 273 (1998) 26179-26186
29. Masuda Y., Nakaya M., Auchi T., Hashimoto S., Nakajo S., and Nakaya K. The mechanism of geranylgeraniol-induced apoptosis involves activation, by a caspase-3-like protease, of a c-jun N-terminal kinase signaling cascade and differs from mechanisms of apoptosis induced by conventional chemotherapeutic drugs. Leuk. Res. 24 (2000) 937-950